Autobio Diagnostics Co., Ltd. Provides Earnings Guidance for the Year 2016
January 23, 2017
Share
Autobio Diagnostics Co., Ltd. provided earnings guidance for the year 2016. For the year, the company predicts a year-on-year increase of between 25% and 40% in the business revenue of between RMB 896 million and RMB 1,003 million, and a year-on-year increase of between 20% and 35% in the net profit owned by shareholders of company of between RMB 334 million and RMB 375 million in 2016.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
AUTOBIO DIAGNOSTICS CO., LTD. 
